Gabapentin in the treatment of bipolar depression in patients with systemic lupus erythematosus.
Carta
M G
MG
Hardoy
M C
MC
Ducci
F
F
Catena
M
M
Dell'Osso
L
L
Carpiniello
B
B
D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D000588:Amines; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy / Q000209:etiology; D003509:Cyclohexanecarboxylic Acids; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000929:Antidepressive Agents, Tricyclic; D018692:Antimanic Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin